Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring

Jiayi Yin, Shiming Zhang, Chao Yang, Yan Wang, Bing Shi, Qian Zheng, Ni Zeng, Hanyao HuangFrontiers in Immunology 2022 · DOI

Abstract

Hypertrophic scarring (HTS) is a major source of morbidity after cutaneous injury. Recent studies indicate that mechanical force significantly impacts wound healing and skin regeneration which opens up a new direction to combat scarring. Hence, a thorough understanding of the underlying mechanisms is essential in the development of efficacious scar therapeutics. This review provides an overview of the current understanding of the mechanotransduction signaling pathways in scar formation and some strategies that offload mechanical forces in the wounded region for scar prevention and treatment.

Introduction: The Mechanical Drivers of Fibrosis

When skin is injured, the biological priority is rapid closure to prevent infection and fluid loss. In adult humans, this speed often comes at the cost of tissue architecture, resulting in fibrotic scars rather than regenerated skin. Hypertrophic scarring (HTS)—characterized by raised, stiff, and often painful tissue—is a significant clinical challenge.

While it has long been observed that mechanical tension exacerbates scarring (e.g., wounds over joints or high-tension areas), the molecular "circuitry" connecting physical force to cellular fibrosis has historically been poorly understood. This review synthesizes current research to explain how mechanical environments dictate the choice between healthy healing and pathological scarring, identifying therapeutic targets that can "offload" these forces at a molecular level.

The Mechanotransduction Circuitry

The process of mechanotransduction—converting physical stimuli into biochemical signals—can be categorized into three distinct layers:

  1. Mechanosensors: Surface proteins such as integrins and ion channels (e.g., Piezo1, TRP) that physically detect stretch and tension in the extracellular matrix (ECM).
  2. Intracellular Signaling Cascades: Relay molecules like Focal Adhesion Kinase (FAK), Rho GTPases, and PI3K/Akt that transmit the signal from the membrane to the cell interior.
  3. Transcriptional Regulation: The final stage where proteins like YAP/TAZ and $\beta$-catenin translocate to the nucleus to activate pro-fibrotic gene expression.
Mechanoreceptors transmit external mechanical forces and activate various intracellular signaling pathways.

Key Insights: The Vicious Cycle of Scarring

A central theme in HTS development is a self-perpetuating feedback loop. Mechanical force activates FAK, which triggers inflammatory responses (via MCP-1). This recruits more fibroblasts, which deposit a stiffer, disorganized ECM. This increased stiffness then generates even more mechanical tension, further driving the scarring process.

Interestingly, inhibiting these pathways does more than just reduce scar size; it can potentially "reprogram" the healing process toward regeneration. For example, blocking the mechanical sensor YAP with verteporfin in murine models has been shown to promote the recovery of hair follicles and sweat glands—structures typically absent in scar tissue.

Therapeutic Potential and Key Results

The review highlights several high-impact experimental results that point toward new clinical strategies:

  • FAK Inhibition: Studies in porcine models demonstrate that FAK inhibitors (e.g., VS-6062) delivered via hydrogels significantly accelerate wound closure while reducing the fibrotic signature of the tissue. Experimental data shows that inhibiting FAK or ERK pathways can markedly reduce the gross scar area under mechanical loading conditions.
FAK and ERK inhibition significantly reduce scar formation in loaded wound models.
  • YAP/TAZ Modulation: Knocking out YAP/TAZ in skin results in delayed wound closure but significantly less fibrosis, confirming their role as a primary "rheostat" for mechanical scarring.
  • Piezo1 Activity: Piezo1-deficient models show reduced wound areas, suggesting this ion channel is a critical gatekeeper for the calcium influx that initiates the scarring response.
  • Clinical Applications: Beyond pharmacological targets, Botulinum toxin A (BTA) is being utilized to temporarily paralyze local muscles, thereby reducing the mechanical pull on healing wounds and improving cosmetic outcomes.

Challenges and Future Directions

Translating these findings from bench to bedside remains complex. Most mechanistic breakthroughs have occurred in murine models; however, human skin's unique thickness and mechanical properties present a significant translational gap. Furthermore, because many of these pathways are essential for initial wound closure, the timing of intervention is critical to avoid wound dehiscence (reopening). Future research must focus on precision delivery systems, such as microneedles and specialized hydrogels, to target these pathways within the optimal therapeutic window.

Summary updated

Abstract

Hypertrophic scarring (HTS) is a major source of morbidity after cutaneous injury. Recent studies indicate that mechanical force significantly impacts wound healing and skin regeneration which opens up a new direction to combat scarring. Hence, a thorough understanding of the underlying mechanisms is essential in the development of efficacious scar therapeutics. This review provides an overview of the current understanding of the mechanotransduction signaling pathways in scar formation and some strategies that offload mechanical forces in the wounded region for scar prevention and treatment.
BibTeX
@inproceedings{yin2022mechanotransduction,
  author = {Jiayi Yin and Shiming Zhang and Chao Yang and Yan Wang and Bing Shi and Qian Zheng and Ni Zeng and Hanyao Huang},
  title = {{Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.1028410},
}
Figure